Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis-Reference-Cited by-同舟云学术

Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis

Published:2017-11-29 Issue:1 Volume:18 Page:101-107
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Toussirot Eric¹²³⁴

Affiliation:

1. INSERM CIC-1431, University Hospital of Besançon, Clinical Investigation Center in Biotherapy, Besançon, France

2. Fédération Hospital-Universitaire INCREASE, University Hospital of Besançon, Besançon, France

3. Department of Rheumatology, University Hospital of Besançon, Besançon, France

4. Department of Therapeutics and EPILAB EA4266: “Epigenetique des infections virales et des maladies inflammatoires”, University of Bourgogne Franche-Comté, Besancon, France

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1410133

Reference50 articles.

1. Psoriatic Arthritis

2. New pathways of treatment for psoriatic arthritis

3. Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders

4. Ixekizumab: First Global Approval

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Skin: The Study of a Bottlebrush Polymer‐Antisense Oligonucleotide Conjugate in a Psoriasis Mouse Model;Small;2024-08-14

2. Molecular and Structural Insights into Buffalo Interleukin-17A;Journal of Interferon & Cytokine Research;2024-05-01

3. Different biologics for biological-naïve patients with psoriatic arthritis: a systematic review and network meta-analysis;Frontiers in Pharmacology;2024-03-13

4. Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials;Arthritis Research & Therapy;2024-02-12

5. Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia;Nature Communications;2024-01-03